糖尿病前期与血糖控制不佳的2型糖尿病作为种植体周围疾病风险指标:系统综述与荟萃分析
该系统综述与荟萃分析纳入35项研究共1761名种植牙患者,评估糖尿病前期及不同血糖控制水平的2型糖尿病与种植体周围状况的关系。结果显示糖尿病前期和血糖控制不佳的2型糖尿病患者种植体周围骨丧失显著增加,而血糖控制良好的2型糖尿病并非种植体周围疾病的风险指标。
要点
- 糖尿病前期患者种植体周围骨丧失平均增加1.2 mm(95%CI 0.4-2.1)。
- 血糖控制不佳的2型糖尿病患者骨丧失平均增加1.8 mm(95%CI 1.0-2.7)。
- 糖化血红蛋白每升高1%,种植体周围骨丧失增加0.24 mm。
核心结论
- 在研究的局限性内,血糖控制不佳的2型糖尿病或糖尿病前期患者可能比无糖尿病及血糖控制良好的2型糖尿病患者有更差的种植体周围状况。
- 血糖控制良好的2型糖尿病不是种植体周围疾病的风险指标。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase和Cochrane图书馆,无筛选或语言限制,并手工检索参考文献列表。
- 纳入队列、病例对照和横断面研究,需回答PECO问题且随访至少1年。
- 从2660条记录中纳入35篇文章,共1761名个体进行分析。
主要发现
- 糖尿病前期患者种植体周围骨丧失的荟萃分析均数差为1.2 mm(95%CI=0.4; 2.1)。
- 血糖控制不佳的2型糖尿病患者骨丧失均数差为1.8 mm(95%CI=1.0; 2.7)。
- 血糖控制良好的2型糖尿病患者骨丧失均数差为0.4 mm(95%CI=-0.3; 1.1)。
- 荟萃回归显示糖化血红蛋白每增加1%,种植体周围骨丧失增加0.24 mm。
关键数值与推荐
- 糖尿病前期定义为HbA1c 5.7-6.4%。
- 2型糖尿病血糖控制良好定义为HbA1c≤8%,控制不佳定义为HbA1c>8%(依据美国糖尿病协会推荐分类)。
临床怎么用
- 临床医生在规划种植修复时应测量血液HbA1c水平,以识别未诊断或控制不佳的2型糖尿病患者。
- 允许在种植手术前调整血糖水平,以确保种植体周围健康。
局限性
- 研究存在局限性,结论需在此范围内解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study answers the PECO question: "In adults with dental implants (P), do subjects suffering from type-2 diabetes or prediabetes (E) have worse peri-implant conditions (O) than subjects without type-2 diabetes and prediabetes (C)?". Prediabetes (5.7-6.4 % HbA1c), and the different qualities of glycemic control in type-2 diabetes; well-controlled (>8 % HbA1c), and poorly controlled (>8 % HbA1c) individuals; were classified according to the recommendations of the American Diabetes Association. DATA: Predefined search keys were used with search terms including: Dental implant, diabetes mellitus, glycemic control and HbA1c. SOURCES: An electronic search in the MEDLINE, Embase, and Cochrane libraries were conducted without any filters or language restrictions. Additionally, manual search of the reference lists were carried out to identify all relevant articles. STUDY SELECTION: Eligibility criteria were cohort, case-control and cross-sectional studies that answerd our PECO question with at least 1 year of follow-up. From a total of 2660 records, 35 articles (1761 individuals) were included in the analysis. Meta-analytic difference in means for crestal bone loss was 1.2 mm [95 % CI=0.4; 2.1] in patients with prediabetes, 1.8 mm [CI=1.0; 2.7] in poorly controlled patients, whereas 0.4 mm [CI=-0.3; 1.1] in well-controlled individuals. Meta-regression showed that 1 % increase in HbA1c increased crestal bone loss by 0.24 mm. CONCLUSIONS: Within the limitations of the study, patients with poorly controlled type-2 diabetes or prediabetes may have worse peri-implant conditions compared to patients without diabetes and well-controlled type-2 diabetes. Well-controlled type-2 diabetes is not a risk indicator for peri-implant diseases. CLINICAL SIGNIFICANCE: Clinicians should measure blood HbA1c levels when planning implant-supported restorations, thus patients with undiagnosed or poorly controlled type-2 diabetes can be identified, that allows for glycemic level adjustment prior to dental implant surgery, ensuring peri-implant health. PROTOCOL REGISTRATION NUMBER: (CRD42022375263).
引用
- Bencze B, Cavalcante BGN, Romandini M, et al. Prediabetes and poorly controlled type-2 diabetes as risk indicators for peri-implant diseases:A systematic review and meta-analysis. J Dent. 2024. PMID: 38788918. doi:10.1016/j.jdent.2024.105094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。